Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of a Protein-Rich, Low-Glycaemic Meal Replacement on Changes in Dietary Intake and Body Weight Following a Weight-Management Intervention-The ACOORH Trial.
Röhling M, Stensitzky A, Oliveira CLP, Beck A, Braumann KM, Halle M, Führer-Sakel D, Kempf K, McCarthy D, Predel HG, Schenkenberger I, Toplak H, Berg A. Röhling M, et al. Nutrients. 2021 Jan 26;13(2):376. doi: 10.3390/nu13020376. Nutrients. 2021. PMID: 33530530 Free PMC article. Clinical Trial.
[Thyroid diseases and pregnancy].
Karger S, Führer-Sakel D. Karger S, et al. Med Klin (Munich). 2009 Jun 15;104(6):450-6. doi: 10.1007/s00063-009-1094-7. Epub 2009 Jun 16. Med Klin (Munich). 2009. PMID: 19533052 Review. German.
Meal replacement by formula diet reduces weight more than a lifestyle intervention alone in patients with overweight or obesity and accompanied cardiovascular risk factors-the ACOORH trial.
Halle M, Röhling M, Banzer W, Braumann KM, Kempf K, McCarthy D, Schaller N, Predel HG, Scholze J, Führer-Sakel D, Toplak H, Berg A; ACOORH study group. Halle M, et al. Eur J Clin Nutr. 2021 Apr;75(4):661-669. doi: 10.1038/s41430-020-00783-4. Epub 2020 Oct 30. Eur J Clin Nutr. 2021. PMID: 33128036 Clinical Trial.
Progression of coronary artery calcification seems to be inevitable, but predictable - results of the Heinz Nixdorf Recall (HNR) study.
Erbel R, Lehmann N, Churzidse S, Rauwolf M, Mahabadi AA, Möhlenkamp S, Moebus S, Bauer M, Kälsch H, Budde T, Montag M, Schmermund A, Stang A, Führer-Sakel D, Weimar C, Roggenbuck U, Dragano N, Jöckel KH; Heinz Nixdorf Recall Study Investigators. Erbel R, et al. Eur Heart J. 2014 Nov 7;35(42):2960-71. doi: 10.1093/eurheartj/ehu288. Epub 2014 Jul 25. Eur Heart J. 2014. PMID: 25062951 Free PMC article.
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY.
Fleseriu M, Führer-Sakel D, van der Lely AJ, De Marinis L, Brue T, van der Lans-Bussemaker J, Hey-Hadavi J, Camacho-Hubner C, Wajnrajch MP, Valluri SR, Palladino AA, Gomez R, Salvatori R. Fleseriu M, et al. Eur J Endocrinol. 2021 Aug 27;185(4):525-538. doi: 10.1530/EJE-21-0239. Eur J Endocrinol. 2021. PMID: 34342594 Free PMC article.
Predicting the Course of Graves' Orbitopathy Using Serially Measured TSH-Receptor Autoantibodies by Automated Binding Immunoassays and the Functional Bioassay.
Stöhr M, Oeverhaus M, Lytton SD, Horstmann M, Zwanziger D, Möller L, Stark A, Führer-Sakel D, Bechrakis N, Berchner-Pfannschmidt U, Banga JP, Philipp S, Eckstein A. Stöhr M, et al. Horm Metab Res. 2021 Jul;53(7):435-443. doi: 10.1055/a-1525-2070. Epub 2021 Jul 19. Horm Metab Res. 2021. PMID: 34282595
Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events: Result of the HNR Study (Heinz Nixdorf Recall).
Lehmann N, Erbel R, Mahabadi AA, Rauwolf M, Möhlenkamp S, Moebus S, Kälsch H, Budde T, Schmermund A, Stang A, Führer-Sakel D, Weimar C, Roggenbuck U, Dragano N, Jöckel KH; Heinz Nixdorf Recall Study Investigators. Lehmann N, et al. Circulation. 2018 Feb 13;137(7):665-679. doi: 10.1161/CIRCULATIONAHA.116.027034. Epub 2017 Nov 15. Circulation. 2018. PMID: 29142010 Free PMC article. Clinical Trial.
46 results